Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome

By sjmartinez • October 5, 2022

Gaylis NB, Ritter A, Kelly SA, Pourhassan NZ, Tiwary M, Sacha JB, Hansen SG, Recknor C, Yang OO. Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome. Clin Infect Dis. 2022 Sep 30;75(7):1232-1234. doi: 10.1093/cid/ciac226. PMID: 35452519; PMCID: PMC9383814.

Tags: CCR5, immunosuppression, Infectious Diseases, leronlimab, long COVID, Publications

Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings

Smith OA, Merritt S, Kompany JP, Hoff NA, Wong TAS, Kamara V, Tambu M, Halbrook M, Kindrachuk J, Barrall AL, Musene K, Martin SA, Berestecky[...]

Virus reactivation in acute and long COVID-19

Maguire C, Chen J, Rouphael N, Morse BA, Hoch A, Pickering H, Phan HV, Glascock A, Chu V, Dandekar R; IMPACC Network; Corry D, Kheradmand[...]

Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An Exploratory Cross-Sectional Analysis

Garcia CY, Chou C, Caso E, Hudspeth JC, Allan-Blitz LT. Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An[...]